65029-36-9 Usage
Description
3H-1,2,4-Triazole-3-thione, 2,4-dihydro-5-(hydroxymethyl)-4-methyl(9CI) is a heterocyclic chemical compound with the molecular formula C6H8N2OS. It features a triazole ring and a thione group, which contribute to its diverse biological activities. 3H-1,2,4-Triazole-3-thione, 2,4-dihydro-5-(hydroxymethyl)-4-methyl(9CI) holds promise for research and development in pharmaceuticals and agrochemicals due to its antiviral, antimicrobial, and antifungal properties.
Uses
Used in Pharmaceutical Industry:
3H-1,2,4-Triazole-3-thione, 2,4-dihydro-5-(hydroxymethyl)-4-methyl(9CI) is used as a pharmaceutical agent for its antiviral, antimicrobial, and antifungal properties. Its diverse biological activities make it a potential candidate for the development of new drugs to combat various infections and diseases.
Used in Agrochemical Industry:
In the agrochemical field, 3H-1,2,4-Triazole-3-thione, 2,4-dihydro-5-(hydroxymethyl)-4-methyl(9CI) is utilized as a bioactive compound with potential applications in crop protection and enhancement of plant health. Its antimicrobial and antifungal properties can be harnessed to create new pesticides or fungicides to protect crops from diseases and pests, thereby increasing agricultural productivity.
Check Digit Verification of cas no
The CAS Registry Mumber 65029-36-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,0,2 and 9 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 65029-36:
(7*6)+(6*5)+(5*0)+(4*2)+(3*9)+(2*3)+(1*6)=119
119 % 10 = 9
So 65029-36-9 is a valid CAS Registry Number.
65029-36-9Relevant articles and documents
Discovery of non-glucoside SGLT2 inhibitors
Li, An-Rong,Zhang, Jian,Greenberg, Joanne,Lee, Taeweon,Liu, Jiwen
scheme or table, p. 2472 - 2475 (2011/05/15)
A series of benzothiazinone and benzooxazinone derivatives were discovered as SGLT2 inhibitors. The optimization led to the discovery of compounds 31 and 32, which exhibited similar potency and better SGLT1 selectivity compared to dapagliflozin. These compounds may provide novel promising scaffolds, which are different from phlorizin-based SGLT2 inhibitors.
Orally active CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological activities of 1-benzazepine derivatives containing a sulfoxide moiety
Seto, Masaki,Miyamoto, Naoki,Aikawa, Katsuji,Aramaki, Yoshio,Kanzaki, Naoyuki,Iizawa, Yuji,Baba, Masanori,Shiraishi, Mitsuru
, p. 363 - 386 (2007/10/03)
In order to develop orally active CCR5 antagonists, 1-propyl- or 1-isobutyl-1-benzazepine derivatives containing a sulfoxide moiety have been designed, synthesized, and evaluated for their biological activities. Sulfoxide compounds containing a 2-pyridyl
